News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn spinout Opus Genetics announced that the first patient has been dosed in its Phase 1/2, first-in-human clinical trial of OPGx-LCA5.
A group of Penn scientists and engineers is moving into 115,000 square feet of new lab space in the 13-story One uCity Square building in West Philadelphia.
The group was named as 2023’s Inno Under 25 honorees by the Philadelphia Business Journal.
Jon Epstein was keynote speaker and Ben Dibling served on a panel discussing science and technology in the context of accelerating innovation.
Microsoft signed a long term contract to purchase up to 315,000 metric tons of CO2 removal over a multi-year period from Penn spinout Heirloom Carbon Technologies.
In September 2023, Penn spinout BlueWhale Bio surfaced with a mission to overhaul cell therapy production.
Exyn has a mission to deliver world-class autonomous robots to data-hungry industries that include mining, logistics and construction.
Penn’s Katalin Karikó, PhD, and Drew Weissman, MD, PhD, have been named winners of the 2023 Nobel Prize in Physiology or Medicine.
The study provides a potential solution for dental caries, also known as tooth decay.
Penn graduates Alex Imbot ‘20 and Eli Moraru ‘21 were featured in the Inquirer for their non-profit corner store idea, The Community Grocer, which improves food access for those using SNAP benefits.